Pfizer, Neuroscience Research Unit | Authors

Articles

The Application Notebook

An Improved SPE-LC–MS–MS Platform for the Simultaneous Quantification of Multiple Amyloid Peptides in Cerebrospinal Fluid for Preclinical or Biomarker Discovery

Fast, flexible platforms for peptide quantification are needed, particularly for a discovery setting. This type of methodology would be especially advantageous in the case of amyloid beta (a?) peptides.